Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 2014

View Archived Issues

Potent c-Ros-1 inhibitors discovered at Janssen and NovAliX

Antiangiogenic and antitumor activity described for alpha-tocopherol analogue

Gene identified as a possible novel biomarker for frontotemporal lobar degeneration

ElexoPharm and Merck & Co. report CYP11B2 inhibitors for heart failure and hypertension

U.S. institutions divulge novel GSK-3 inhibitors

Loxo Oncology initiates phase I study of Trk inhibitor for cancer

Covagen initiates first clinical trial of FynomAb bispecific inhibitor

Addition of VX-661 to Kalydeco improves lung function in phase II trial in CF

Promising preclinical results for a novel, live-attenuated plague vaccine

Ruthigen submits IND for anti-infective surgical lavage

Phase III ovarian cancer trial of vintafolide stopped due to lack of efficacy

Camicinal proves well tolerated in diabetic patients with gastroparesis

Bristol-Myers Squibb describes novel FXIa inhibitors

New macrocyclic ketoamides disclosed by Roche

Bristol-Myers Squibb updates pipeline progress of first quarter 2014

NIH gives grant to Scripps Research Institute to develop diagnostics

Cellectar Biosciences' glioma diagnostic obtains FDA orphan drug designation

diaDexus completes validation study for PLAC Test for Lp-PLA2 Activity

Advaxis' immunotherapy product to enter clinic for pediatric bone cancer

ADDF raises funding for trial investigating rasagiline for Alzheimer's disease

Pierre Fabre obtains European approval for Hemangiol

World Asthma Day: Disease control through discovery of new therapeutic targets and models

Acorda receives complete response letter from FDA for Plumiaz

FDA approves Epanova for hypertriglyceridemia

FDA approves IND for Kinex's Oratecan

Alexion achieves regular approval for Soliris in aHUS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...